Skip to main content

North Carolina Macular Dystrophy

  • Chapter
  • First Online:
Hereditary Chorioretinal Disorders

Part of the book series: Retina Atlas ((RA))

  • 576 Accesses

Abstract

North Carolina macular dystrophy (NCMD) is a congenital, developmental abnormality of the macula. It was first described in families living in western North Carolina by Lefler, Wadsworth, and Sidbury in 1971 and initially called autosomal dominant macular degeneration and aminoaciduria (Lefler et al. 1971). Subsequently this disease became known as the Lefler Wadsworth Sidbury syndrome. However, the aminoaciduria was later found to not consistently manifest in the affected family members, making this a misnomer in that it is not a syndrome at all. J Donald M. Gass, MD named NCMD after the founder effect of this initial family in his textbook Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment (Gass 1997). However, NCMD has now been described in many unrelated families from the United States, the United Kingdom, France, Germany, Korea, and Belize (Small 1998; Reichel et al. 1998; Pauleikhoff et al. 1997).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bosse A, Zulch A, Becker MB, et al. Identification of the vertebrate Iroquois homeobox gene family with overlapping expression during early development of the nervous system. Mech Dev. 1997;69:169–81.

    Article  CAS  Google Scholar 

  • Cheng CW, Chow RL, Lebel M, et al. The Iroquois homeobox gene, Irx5, is required for retinal cone bipolar cell development. Dev Biol. 2005;287:48–60.

    Article  CAS  Google Scholar 

  • Cipriani V, Silva RS, Arno G, et al. Duplication events downstream of IRX1 cause North Carolina macular dystrophy at the MCDR3 locus. Sci Rep. 2017;7:7512.

    Article  Google Scholar 

  • Fetkenhour CL, Gurney N, Dobbie JG, Choromokos E. Central areolar pigment epithelial dystrophy. Am J Ophthalmol. 1976;81:745–53.

    Article  CAS  Google Scholar 

  • Gass JDM. Stereoscopic atlas of macular diseases: diagnosis and treatment. St. Louis: Mosby; 1997.

    Google Scholar 

  • Hermsen VM, Judisch GF. Central areolar pigment epithelial dystrophy (with 1 color plate). Ophthalmologica. 1984;189:69–72.

    Article  CAS  Google Scholar 

  • Lefler WH, Wadsworth JA, Sidbury JB Jr. Hereditary macular degeneration and amino-aciduria. Am J Ophthalmol. 1971;71:224–30.

    Article  CAS  Google Scholar 

  • Leveille AS, Morse PH, Kiernan JP. Autosomal dominant central pigment epithelial and choroidal degeneration. Ophthalmology. 1982;89:1407–13.

    Article  CAS  Google Scholar 

  • Pauleikhoff D, Sauer CG, Muller CR, Radermacher M, Merz A, Weber BH. Clinical and genetic evidence for autosomal dominant North Carolina macular dystrophy in a German family. Am J Ophthalmol. 1997;124:412–5.

    Article  CAS  Google Scholar 

  • Reichel M, Kelsell R, Fan J, et al. Phenotype of a British North Carolina macular dystrophy family linked to chromosome 6q. Br J Ophthalmol. 1998;82:1162–8.

    Article  CAS  Google Scholar 

  • Rosenberg T, Roos B, Johnsen T, et al. Clinical and genetic characterization of a Danish family with North Carolina macular dystrophy. Mol Vis. 2010;16:2659–68.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Small KW. North Carolina macular dystrophy, revisited. Ophthalmology. 1989;96:1747–54.

    Article  CAS  Google Scholar 

  • Small KW. North Carolina macular dystrophy: clinical features, genealogy, and genetic linkage analysis. Trans Am Ophthalmol Soc. 1998;96:925–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Small KW. Indentifying the genetic mutation for North Carolina dystrophy. Retina Physician. 2017;29–32.

    Google Scholar 

  • Small KW, Killian J, McLean WC. North Carolina’s dominant progressive foveal dystrophy: how progressive is it? Br J Ophthalmol. 1991a;75:401–6.

    Article  CAS  Google Scholar 

  • Small KW, Weber JL, Hung WY, Vance J, Roses A, Pericak-Vance M. North Carolina macular dystrophy: exclusion map using RFLPs and microsatellites. Genomics. 1991b;11:763–6.

    Article  CAS  Google Scholar 

  • Small KW, DeLuca AP, Whitmore SS, et al. North Carolina macular dystrophy is caused by dysregulation of the retinal transcription factor PRDM13. Ophthalmology. 2016;123:9–18.

    Article  Google Scholar 

  • Watanabe S, Sanuki R, Sugita Y, et al. Prdm13 regulates subtype specification of retinal amacrine interneurons and modulates visual sensitivity. J Neurosci Off J Soc Neurosci. 2015;35:8004–20.

    Article  CAS  Google Scholar 

  • Weleber RG. Dysregulation of retinal transcription factor PRDM13 and North Carolina macular dystrophy. Ophthalmology. 2016;123:2–4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Small, L., Small, K., Shaya, F. (2020). North Carolina Macular Dystrophy. In: Cheung, G. (eds) Hereditary Chorioretinal Disorders. Retina Atlas. Springer, Singapore. https://doi.org/10.1007/978-981-15-0414-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0414-3_7

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0413-6

  • Online ISBN: 978-981-15-0414-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics